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Palatal myoclonusAbstract Background and purpose: Hypertrophic olivary degeneration (HOD) is a rare transsy-
naptic degeneration that usually appears at around 3–4 weeks following an injury to the Guil-
lain–Mollaret triangle, resulting in three possible patterns. Our purpose was to describe those
MRI features linking them to their corresponding neurological manifestations and possible prior
location of brain insults based on our own experience compared to the review of the literature.
Methods: Six patients with clinically evident new neurological symptoms not explained by the ini-
tial brain insult were included. All patients were subjected to complete neurological assessment by
neurologist or neurosurgeon accordingly. Review of their prior and recent MRI studies as well as
CT if available was carried out by two neuroradiologists who picked up the different but classical
patterns of HOD on the latest imaging studies.
Results: The 6 patients had old brain insults including old hematomas (1 patient), old infarctions (3
patients) and hemorrhagic vascular malformation (2 patient) involving the afferent components of
the Guillain–Mollaret triangle with development of new movement disorders including ataxia (4
patients), palatal myoclonus (4 patients), tremors (1 patient) and nystagmus (2 patients). MRI
clearly showed the nature of the initial lesions. High T2 signal intensity was noticed at the inferior
olivary nucleus (ION) in all patients representing olivary degeneration. The size of the ION was
enlarged with rounded conﬁguration in 5 cases thus considered hypertrophic, while the size of
the ION was shrunken in one case and considered atrophic. The examined ION showed no
restricted diffusion excluding recent infarction, blooming on T2* excluding hemorrhage or post con-
trast enhancement excluding inﬂammation or neoplasm. Unilateral HOD was seen in 3 cases
involving the contra-lateral ION while bilateral HOD was seen in 3 cases.edicine,
Fig. 1 We have created this simp
anatomy of the Guillain–Morlet. R
nucleus (DN), inferior olivary nucleu
nucleus (SCP), inferior cerebellar ped
tal tract (CTT).
1020 A. Elnekiedy et al.Conclusion: HOD is an infrequent neurological pathology, sequel to Guillain and Mollaret triangle
affection that involves a wide range of symptomatology. It manifests as enlargement of the ION
with high T2 and FLAIR signal without enhancement, restricted diffusion or blooming on T2*
or SWI.
 2016 The Egyptian Society of Radiology and Nuclear Medicine. Production and hosting by Elsevier.
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nd/4.0/).1. Introduction
The dentate-rubral-olivary connections were described by
Guillain and Mollaret (1) in 1931, thus referred to as the Guil-
lain–Mollaret triangle which is a triangular circuit connecting
the dentate nucleus (DN) of the cerebellum of one side with
the red nucleus (RN) and the inferior olivary nucleus (ION)
of the other side. The triangle consists of a set of afferent
and efferent tracts. The afferent pathway to the olives origi-
nates in the dentate nucleus and travels through the superior
cerebellar peduncle (SCP) to enter the contra-lateral red
nucleus (dentate-rubral tract). It then traverses downwards
through the central tegmental tract (CTT) to connect the red
nucleus with the contra-lateral ION. Efferent ﬁbers from the
ION then cross superiorly through the inferior cerebellar
peduncle (ICP) back to the dentate nucleus (olivo-cerebellar
tract) (2) (Fig. 1).
Hypertrophic olivary degeneration (HOD) is a rare transsy-
naptic degeneration that usually appears at around 3–4 weeks
following an injury to the Guillain–Mollaret triangle. T2
hyperintensity and enlargement of the inferior olivary nucleus
(ION) are the radiological hallmarks of this entity. On follow-
up imaging, the ION can be hypertrophic or lately atrophic
and can persist for years. HOD is considered a orthodox type
of degeneration because it is associated with enlargement,
rather than atrophy observed in other parts of the central ner-
vous system (3).
Patients may display no clinical manifestations attributable
to HOD or may exhibit speciﬁc presentations such as palatal
myoclonus, nystagmus, tremors or ataxia. Thus, it is important
to recognize the radiological ﬁndings of HOD, especially in
young patients, in order to avoid misinterpretation of this
benign condition (4).liﬁed diagram to show the
ed nucleus (RN), dentate
s (ON), superior cerebellar
uncle (ICP), central tegmen-Disruption of Guillain and Mollaret triangle results in three
potential forms of HOD. Ipsilateral ION involvement is the
result of central tegmental tract affection by lesions targeting
the brain stem tegmentum, while contralateral ION degenera-
tion by lesions affecting the dentate nucleus or the superior
cerebellar peduncle. Lastly, a para-median pontine lesion near
the superior cerebellar peduncle results bilateral ION degener-
ation due to simultaneous involvement of the central tegmental
tract and the superior cerebellar peduncle (5,6) (Fig. 2).
2. Aim of the work
Our purpose was to describe those MRI features linking them
to their corresponding neurological manifestations and possi-
ble prior location of brain insults based on our own experience
compared to the review of the literature.
3. Patients and methods
Six patients with clinically evident recently developed neuro-
logical symptoms not explained by the initial brain insult were
included. They were 5 males and 1 female with age ranging
between 39 and 69 years. They had old brain lesions at the
pons, midbrain, superior cerebellar peduncle (SCP) and cere-
bellum, not explaining the new symptomatology. These old
insults occurred 3, 6, 7, 1, 1 and 4 years ago in each patient
respectively while their recent MRI were done 1–3 months
after the onset of the newly developed neurological deﬁcits.
Approval of the ethic committee at our university was
obtained for conduction of this study with fulﬁllment of ethic
committee guidelines. An informed written consent was taken
with exclusion of patients with known demyelination disor-
ders, metastasis or inﬂammatory brain diseases.
All patients were subjected to complete neurological assess-
ment by expert neurologist or neurosurgeon accordingly.
Review of their prior and recent MRI studies as well as CT
if available was carried out by two expert neuroradiologists
(15 and 18 years of experience) in contentious in an attempt
to demonstrate the underlying imaging ﬁndings causative of
the novel symptomatology.
The brain MRI studies were conducted using 1.5-T closed
MR unit (Avanto, Siemens, Germany) in 5 patients. The fol-
lowing MRI sequences were performed, including (a) Axial
and coronal T2 weighted turbo spin echo (T2 TSE) utilizing
the following parameters: A repetition time (TR) of 3000 ms,
an echo time (TE) of 120 ms, a slice thickness of 3 mm, a
gap of 0.3 mm, 256  256 acquisition matrix, and
FOV= 180 mm given an acquisition time of 2 min 51 s. (b)
Axial and sagittal T1 weighted spin echo (T1 TSE) utilizing
the following parameters: TR of 550 ms, a TE of 15 ms, a
256  256 acquisition matrix, a ﬁeld of view of 180 mm, a slice
Fig. 2 We have created this simpliﬁed diagram to show Guillain–Morlet triangle and possible patterns of hypertrophic olivary
degeneration (HOD) related to location of the lesion. Red nucleus (RN), dentate nucleus (DN), inferior olivary nucleus (ON), superior
cerebellar nucleus (SCP), inferior cerebellar peduncle (ICP), central tegmental tract (CTT).
MRI of hypertrophic olivary degenertion 1021thickness of 3 mm and a gap of 0.3 mm, given an acquisition
time of 3 min 23 s. (c) Axial FLAIR utilizing the following
parameters: TR of 8000 ms, a TE of 138 ms, TI 2000 ms a ﬁeld
of view of 180 mm, a slice thickness of 3 mm and a gap of
0.3 mm. (d) Susceptibility weighted MRI utilizing the follow-
ing parameters: TR of 6400 ms, a TE of 30 ms, a 256  256
acquisition matrix, a ﬁeld of view of 280 mm, a slice thickness
of 2.4 mm and a gap of 0.2 mm, given an acquisition time of
3 min, with minIP reconstruction for the images. (e) Diffusion
weighted axial MRI imaging with B0 and B1000 values as well
as apparent diffusion coefﬁcient (ADC) map reconstruction.
Post intravenous injection of contrast (Gadolinium-DTPA)
2-moml/kg the T1 axial, coronal and sagittal sequences are
repeated.
The brain MRI in the 6th patient was conducted using open
MR unit (Magnetom C, Siemens, Germany). The following
MRI sequences were performed, including (a) Axial and coro-
nal T2 weighted turbo spin echo (T2 TSE) utilizing the follow-
ing parameters: A repetition time (TR) of 2800 ms, an echo
time (TE) of 110 ms, a slice thickness of 4 mm, a gap of
0.4 mm, 256  256 acquisition matrix, FOV = 180 mm given
an acquisition time of 4 min. (b) Axial and sagittal T1
weighted spin echo (T1 TSE) utilizing the following parame-
ters: TR of 400 ms, a TE of 25 ms, a 256  256 acquisition
matrix, a ﬁeld of view of 180 mm, a slice thickness of 4 mm
and a gap of 0.4 mm, given an acquisition time of 4 min
30 s. (c) Axial FLAIR utilizing the following parameters: TR
of 8400 ms, a TE of 130 ms, TI 2000 ms a ﬁeld of view of
180 mm, a slice thickness of 4 mm and a gap of 0.4 mm. (d)T2* weighted MRI utilizing the following parameters: TR of
6400 ms, a TE of 30 ms, a 256  256 acquisition matrix, a ﬁeld
of view of 180 mm, a slice thickness of 4 mm and a gap of
0.4 mm, given an acquisition time of 3 min. (e) Diffusion
weighted axial MRI imaging with B0 and B1000 values as well
as apparent diffusion coefﬁcient (ADC) map reconstruction.
Post intravenous injection of contrast (Gadolinium-DTPA)
2-moml/kg the T1 axial, coronal and sagittal sequences are
repeated.
Image interpretation included thorough assessment of the
inferior olivary nuclei as regards:
1. The signal intensity; where high T2 signal intensity of the
ION was determined by comparing to images of other
healthy persons as well as by comparing images of the
contra-lateral ION if the affection is unilateral.
2. The volume alteration of the inferior olivary nucleus; where
enlarged and rather rounded shape of the ION was consid-
ered hypertrophic, while small and shrunken ION were
considered atrophic. This is achieved by comparing to the
contralateral nucleus in the same patient or in other age
matching patients without brain stem insults.4. Results
The examined 6 patients had variable old brain insults includ-
ing old hematomas (1 patient), old infarctions (3 patients) and
hemorrhagic vascular malformation (2 patient) involving the
afferent components of the Guillain–Mollaret triangle.
Fig. 3 50 y male patient with chronic hypertensive encephalopathy MRI revealed chronic hypertensive encephalopathy in the form of
multiple peripheral and central micro-bleeds expressing blooming foci on T2* WI (a–c) in addition to old larger hematomas at the left
posterior aspect of the pons and midbrain as well as at the left parietal and temporal lobes also there are old non hemorrhagic lacunar
infarcts at the tegmentum of the pons (d). Bilateral almost symmetrical enlargement and T2 high signal are noted at the inferior olivary
nuclei without enhancement, restricted diffusion or blooming on T2* representing bilateral hypertrophic olivary degeneration (e and f).
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Fig. 4 60 y female patient with multiple strokes since 6 years as well as recent ataxia, tremors, quadriparesis and nystagmus without
palatal myoclonus 1 year after initial lesion. MRI revealed an old infarction at the right occipital lobe and multiple non hemorrhagic
lacunar infarcts at the right crus cerebri, central portion of the pons and both cerebellar hemispheres (a–c) in addition to bilateral almost
symmetrical T2 high signal at the anterior olivary nuclei with subtle atrophy but without enhancement, restricted diffusion or blooming on
T2* representing bilateral olivary degeneration (d).
MRI of hypertrophic olivary degenertion 1023Checking the time line of the inferior olivary nuclei involve-
ment, it was noted that the initial insults occurred 1–7 years
before their inclusion in this study, while the new neurological
manifestations developed 3 months to 2 years thereafter,
including ataxia (4 patients), palatal myoclonus (4 patients),
tremors (1 patient) and nystagmus (2 patients), with four
patients presenting with more than one of the above-
mentioned abnormal movements.
MRI clearly showed the nature of the initial lesions as
follows:
1. Infarctions perceived as areas of T2 high signal, T1 and
FLAIR low signal.
2. Old hematomas express heterogeneous T1 and T2 signal
with foci of dark T1 and T2 signals due to hemosiderin
deposition with blooming on T2* or SWI.3. Hemorrhagic vascular malformation expressed heteroge-
neous T1 and T2 signal with foci of dark T1 and T2 signal
due to hemosiderin deposition with blooming on T2* or
SWI, while corresponding CT with contrast revealed
dilated enhancing abnormal veins denoting mixed caver-
noma and venous angioma or developmental venous
anomaly.
4. Hemorrhagic vascular malformation expressed heteroge-
neous T1 and T2 signal with foci of dark T1 and T2 signal
due to hemosiderin deposition with blooming on T2* or
SWI, denoting a hemorrhagic cavernoma still with normal
ION. A follow-up after 4 years revealed mild regression of the
cavernoma with development of contralateral ION changes.
On the other hand, inspecting the inferior olivary nuclei,
the following was depicted:
Fig. 5 39 years oldmale patient with right hemiplegia since 7 years with evolved ataxia and palatal myoclonus in the last 5 years. The latest
MRI and enhanced CT revealed mixed developmental venous anomaly (DVA) and multiple cavernomata seen at the left middle and
superior cerebellar peduncles, left side of pons and left cerebellar lobe (a–g) as well as right sided unilateral enlargement and T2 high signal at
the anterior olivary nucleus without enhancement or blooming on T2* representing unilateral hypertrophic olivary degeneration (h and i).
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Fig. 6 49 years old male patient with right hemiparesis and left ophthalmoplegia since 1 year and developed palatal myoclonus in the
last 6 months. MRI revealed old linear infarction at the left side of the tegmentum of the midbrain extending to the left superior colliculus
(a) in addition to unilateral enlargement and T2 high signal at the right inferior olivary nucleus without enhancement or blooming on T2*
representing unilateral hypertrophic olivary degeneration (b–d).
MRI of hypertrophic olivary degenertion 10251. High T2 signal intensity was detected at the ION in all
patients representing olivary degeneration.
2. The size of the ION was enlarged with rounded conﬁgura-
tion in 5 cases thus considered hypertrophic, while the
size of the ION was shrunk in one case and considered
atrophic.
3. None of the examined ION showed:
a. Restricted diffusion excluding recent infarction.
b. Blooming on T2* excluding hemorrhage.
c. Post contrast enhancement excluding inﬂammation or
neoplasm.Unilateral HOD was noted in 3 cases involving the contra-
lateral ION, while bilateral HOD was seen in 3 cases.
Table 1 summarizes the neurological manifestations and
MRI ﬁndings in each patient.5. Discussion
The usual outcome of degenerated parts of the central nervous
system is atrophy, which is not the case in HOD, which is
deﬁned as a transsynaptic form of degeneration causing rather
Fig. 7 A 35 y male patient with right hemiplegia. MRI done 4 years earlier shows hemorrhagic pontine cavernoma (a) with normal ION
(b), Follow-up MRI done after 4 years revealed mild size regression of the pontine cavernoma (c) and development of contralateral
unilateral HOD (d and e).
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(ION (3,5)).
Although the Guillain and Mollaret pathway has been
described as a triangle, pathologies involving the afferent
(dentato-rubral or rubro-olivary pathway) and not efferent
(olivodentate pathway) ﬁbers are the underlying cause for
HOD (7,8).
The efferent ﬁbers from the ION do not communicate
straight with the dentate nucleus; but relay in the cerebellar
cortex via the olivo-cerebellar tract before projecting to the
dentate nucleus. That is why lesions of the inferior cerebellar
peduncle (olivodentate tract) do not cause HOD. The olivo-
dentate tract plays role in maintaining the cerebellar hemi-
spheres, so lesions of this tract cause cerebellar atrophy (9).
This cerebellar nourishing role of the oliva is supported by
the atrophy of the cerebellar cortex and dentate nucleus
contra-lateral to an oliva with HOD (10). None of our cases
showed this phenomenon of contralateral cerebellar atrophy.The prior insults in our patients included old hematomas
(1 patient), old infarctions (3 patients) and vascular malforma-
tion (2 patients). Similar lesions were reported in the literature
in addition to trauma (6,11,12). There are very few reported
cases in the literature mentioning post-operative HOD for
management of primary brain stem or cerebellar lesions pon-
tine such as cavernous haemangioma, low-grade cerebellar
tumor and a posterior fossa epidermoid (13,14).
Sanverdi et al. (4) reported a case of idiopathic degenera-
tion of the ION presented with bilateral HOD without visible
lesion in Guillain and Mollaret triangle or clinical manifesta-
tion of HOD. Also a few reports in the literature described
metronidazole-induced encephalopathy that presented as
HOD in adulthood (15).
All our patients were adults; however, HOD was reported
in pediatric ages with similar MRI and clinical ﬁndings (4).
Disruption of Guillain and Mollaret triangle results in three
possible patterns of HOD as detailed in the introduction sector
Table 1 Summary of the clinical and MRI ﬁndings of the included 6 patients.
Patient Age and clinical presentation MRI ﬁndings Pattern of hypertrophic olivary
degeneration
Diagnosis
1
(Fig. 3)
50 y male patient with chronic
hypertensive encephalopathy, right
hemiplegia since 3 years, then
developed ataxia and palatal
myoclonus 6 months after initial ictus
Multiple peripheral and central
micro-bleeds and old hematomas at
the left posterior aspect of the pons
and midbrain as well as at the left
parietal and temporal lobes
Bilateral almost symmetrical
enlargement and T2 high signal at the
inferior olivary nuclei without
enhancement, restricted diﬀusion or
blooming on T2*
Bilateral
HOD
2
(Fig. 4)
60 y female patient with multiple
strokes since 6 years as well as recent
ataxia, tremors quadriparesis and
nystagmus without palatal
myoclonus 1 year after initial lesion
Multiple non hemorrhagic lacunar
infarcts at the right crus cerebri, both
sides of the pons and both cerebellar
hemispheres
Bilateral almost symmetrical T2 high
signal at the inferior olivary nuclei
with atrophy. Seen at the IONNo
enhancement, restricted diﬀusion or
blooming on T2*
Bilateral
HOD
3
(Fig. 5)
39 years old male patient with right
hemiplegia since 7 years with evolved
ataxia and palatal myoclonus in the
last 5 years
Mixed DVA and multiple
cavernomata seen at the left middle
cerebellar peduncle left side of pons
and left cerebellar lobe
Right sided unilateral enlargement
and T2 high signal at the inferior
olivary nucleus without
enhancement, restricted diﬀusion or
blooming on T2*
Unilateral
HOD
Contralateral
4
(Fig. 6)
49 years old male patient with right
hemiparesis and left ophthalmoplegia
since 1 year and developed palatal
myoclonus in the last 6 months
Old linear infarction at the left side of
the midbrain tegmentum and
superior colliculus
Right sided unilateral enlargement
and T2 high signal at the inferior
olivary nucleus without enhancement
or blooming on T2*
Unilateral
HOD
Contralateral
5 69 y male patient with right
hemiparesis since 1 year and recently
developed ataxia and nystagmus
without palatal myoclonus in the last
3 months
Chronic linear infarction at the left
cerebral peduncle and another one at
the anterior aspect of the pons
Bilateral almost symmetrical
enlargement and T2 high signal at the
inferior olivary nuclei without
enhancement, restricted diﬀusion or
blooming on T2*
Bilateral
HOD
6
(Fig. 7)
A 35 y male patient with right
hemiplegia since 4 years due to a
pontine bleeding cavernoma, recently
developed ataxia and palatal
myoclonus
MRI done 4 years earlier shows
hemorrhagic pontine cavernoma with
normal ION, Follow-up MRI done
after 4 years revealed mild size
regression of the pontine cavernoma
and development of contralateral
unilateral HOD
Right sided unilateral enlargement
and T2 high signal at the inferior
olivary nucleus without
enhancement, restricted diﬀusion or
blooming on T2*
Unilateral
HOD
Contralateral
MRI of hypertrophic olivary degenertion 1027of this paper providing explanation to the patterns of HOD
seen in our patients.
Several authors (16,17,4) reported that HOD is commonly
unilateral with rarity of bilateral cases; conversely, three out
of the six patients included in our study had bilateral HOD
denoting that bilateral HOD is not that uncommon. The pri-
mary insults in these three patients targeted the dentate-
rubral tract and the central tegmental tract simultaneously.
The remaining three patients presented with unilateral
HOD contra-lateral to the primary lesions that involved left
cerebellar lobe including the dentate nucleus and the left supe-
rior cerebellar peduncle in two cases as well as the pons in one
case. No case of ipsilateral HOD was observed in the current
study. There is one reported case in the literature in which
exhibited unilateral cerebellar ischemic lesion that occurred
during craniotomy with consequent bilateral HOD, still the
reason for this is unclear (18).
HOD is not seen immediately after the initial ictus, but typ-
ically appears in a delayed fashion (19). This was clear in our
patients who presented with HOD 3 months to 4 year after the
initial insult.
Many studies described the pathological changes of HOD
and corresponding MRI ﬁndings (19,20). The initial T2 signal
hyperintensity correlates with the demyelination and edema.
Neuronal hypertrophy begins 20–30 days after the initial
insult, and reaches maximum size 6–7 months later, accompa-
nied by astrocytosis and synaptic and axonal remodeling.Early hypertrophy correlates with ballooning of the neurons
and increased numbers of protoplasmic astrocytes. At
6 months, there is further olivary enlargement with evolution
of vacuoles in the ballooned neurons. Maximum hypertrophy
of ION and signal intensity changes persist until 18 months,
followed by resolution of hypertrophy and some persistent
high signal within the ION. The hypertrophic changes decrease
with time then atrophy starts. After 2 years, the number of
neurons decreases progressively that at 6 years after the insult,
there is 90% or more reduction in the normal number of neu-
rons (9,19–22).
This stepwise MRI changes can explain atrophy rather than
hypertrophy of the ION seen in one of our patients who was
imaged after 4 years of initial ictus.
HOD is a rare but clinically relevant condition. Patients
with HOD often present with palatal myoclonus, ataxia, dys-
arthria, hemiparesis (9), Holmes’ tremor and/or ocular myo-
clonus (23).
In the current study, four patients presented with palatal
myoclonus that started 3–24 months after the initial ictus.
Palatal myoclonus (Palatal tremor) has been described as a
rhythmic involuntary movement of the oropharynx, including
the soft palate and uvula (24). Palatal myoclonus is a rare
movement disorder and is classiﬁed into two forms: symp-
tomatic and essential. Symptomatic palatal tremor is usually
the result of a lesion in the triangle of Guillain and Mollaret
and is associated with HOD. It develops nearly a year
1028 A. Elnekiedy et al.following initial ictus, although it does not always correlate
with olivary hypertrophy. Severe myoclonus of the cervical
muscles and the diaphragm has been reported and can precede
palatal myoclonus (25).
Patients with essential palatal tremor have no deﬁnable
cause, no accompanying neurologic ﬁndings, and no MR
changes suggestive of HOD. This palatal tremor can produce
a self-audible clicking sensation due to activation of the levator
veli palatini muscle innervated by the ninth cranial nerve (10).
One of the above described 4 patients with palatal myoclo-
nus presented with upper extremity tremors beginning earlier
before the palatal tremors. Dentatorubral (or Holmes’) tremor
includes an unusual combination of 2–5 Hz rest, postural and
kinetic tremor of an upper extremity. Similar to our case, there
have been few cases describing the development of palatal tre-
mor sometime after the appearance of Holmes’ tremor (23). In
our study ataxia was also identiﬁed in 4 patients and nystag-
mus in 2 patients.
Palatal myoclonus, and other involuntary movements, may
proceed HOD and may be visible after the hypertrophy
resolves (6,7). These symptoms may be due to lack of inhibi-
tory control that is transmitted through the dentatorubral
pathway. Palatal Myoclonus is caused by hyperactivity of
the olivary neurons until the peak of HOD. Disturbance of
natural rhythmicity and lack of feedback may explain persis-
tence of these movement disorders after resolution of HOD
(9,26).
HOD is a usually a self-limiting disease that is managed by
symptomatic treatment. Palatal myoclonus may respond to
medications such as valproic acid, carbamazepine and clon-
azepam. Botulinum toxin injections into the tensor veli pala-
tine muscle are reserved to severe cases of palatal myoclonus
(9).
On analysis of the lesions at the ION in our patients, the
signal was high on T2 and FLAIR sequences without restricted
diffusion or post contrast enhancement with clear evidence of
a proximal insult at the afferents of the ION within the Guil-
lain and Mollaret triangle.
The differential diagnosis of signal hyperintensity in the
antero-lateral part of the medulla includes infarction, demyeli-
nation, tumor and inﬂammatory processes. The absence of
contrast enhancement is against several pathologies such as
tumors including astrocytoma, lymphoma and metastasis or
infection, while the usually identiﬁed additional enlargement
of the olivary nucleus is against chronic stages of infarction
or multiple sclerosis. Diffusion weighted imaging (DWI) helps
to rule out acute infarction or acute cerebritis (27).
Thus, signal changes conﬁned to the olivary nucleus or
nuclei (with or without enlargement of the ION), lack of con-
trast enhancement or diffusion restriction in addition to the
presence of an inciting lesion in the brain stem or cerebellum
should point toward the diagnosis of HOD. Correct identiﬁca-
tion of HOD is essential in preventing missing such benign
condition with possible misdirected interventions (12).
Bouz et al. (9) recently reported a case referred to their
institution for biopsy of a presumed ‘‘medullary glioma.” After
careful review of the case, the diagnosis of HOD was made and
conﬁrmed by the patient’s clinical course that showed slow but
steady improvement.6. Conclusion
HOD is a rare pathological entity that presents with a spec-
trum of neurological manifestations. It appears to be a delayed
end-result of insult to a Guillain and Mollaret triangle. It man-
ifests as enlargement of the ION with high T2 and FLAIR sig-
nal without enhancement, restricted diffusion or blooming on
T2* or SWI.
A multidisciplinary approach involving the collaboration of
both clinicians, whether neurologists or neurosurgeons and
radiologists is a must to reach the correct diagnosis of HOD
among other differentials in cases presenting with both
enlarged anterior medullary lesions and posterior fossa lesions
especially if the latter proved to be preceding in prior imaging
studies to prevent in misdirected interventions.
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